コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ut the acyl transfer onto Rv0100 rather than coenzyme A.
2 es its activity by disrupting the binding of coenzyme A.
3 structure of PBCV-1 A654L in a complex with coenzyme A.
4 substituted amino acid aldehydes and malonyl-coenzyme A.
5 he peptide N-myristoylated-GCG and palmitoyl-coenzyme A.
6 sm of living organisms and forms the core of coenzyme A.
9 s conversion of acetyl coenzyme A to malonyl coenzyme A, a carbon donor for long-chain FA synthesis,
11 the transfer of an acetyl group from acetyl-coenzyme A (Ac-CoA) to the amine of a wide range of subs
12 with inositol hexaphosphate (InsP6), acetyl-coenzyme A (AcCoA) and/or substrate Resistance to Ralsto
14 at catalyzes pyruvate's conversion to acetyl coenzyme A (AcCoA), thereby connecting these two pathway
15 ased levels of acetyl phosphate, acetoacetyl coenzyme A (acetoacetyl-CoA), butyryl CoA, acetoacetate,
16 d ferredoxin for glucose oxidation to acetyl coenzyme A (acetyl-CoA) and CO2, NADH for the reduction
17 in conversion of acetyl phosphate to acetyl-coenzyme A (acetyl-CoA) and posttranscriptionally regula
18 oumarate to p-hydroxybenzaldehyde and acetyl coenzyme A (acetyl-CoA) encoded by the couAB operon.
23 rnative carbon source utilization for acetyl coenzyme A (acetyl-CoA) production and gluconeogenesis.
24 ferentiation in a manner dependent on acetyl coenzyme A (acetyl-CoA) production by the enzyme ATP-cit
25 esis by suppressing the expression of acetyl coenzyme A (acetyl-CoA) synthetase (Acss), leading to de
26 main-containing enzyme that condenses acetyl coenzyme A (acetyl-CoA) with malonyl-acyl carrier protei
27 d is sensitive to the availability of acetyl coenzyme A (acetyl-CoA), we investigated a role for meta
29 e, enabling biosynthesis of cytosolic acetyl coenzyme A (acetyl-CoA, the two-carbon isoprenoid precur
31 to a promoter region shared with the acetyl coenzyme-A acyl-transferase-1 (ACAA1), was associated wi
32 copurify with the Golgi adaptor protein acyl coenzyme A (acyl-CoA) binding domain protein 3 (ACBD3/GP
33 n architecturally distinct subfamily of acyl coenzyme A (acyl-CoA) dehydrogenase (ACAD) enzymes that
35 confirmed a preference for short-chain acyl coenzyme A (acyl-CoA) substrates, supporting the identif
37 s or longer rescue growth by generating acyl coenzyme A (acyl-CoA) thioester beta-oxidation degradati
38 activity of the long-chain cytoplasmic acyl coenzyme A (acyl-CoA) thioesterase 7 (ACOT7) to regulate
39 nd di-, poly-, and persulfide derivatives of coenzyme A, although polysulfide itself is also efficien
40 PqsBC catalyzes the condensation of octanoyl-coenzyme A and 2-aminobenzoylacetate (2-ABA) to form the
41 best inhibitors are competitive with acetyl coenzyme A and an X-ray cocrystal structure reveals that
42 amide synthase that uses C16 fatty acid acyl-coenzyme A and dihydroxy LCB substrates but increased ac
43 e enzyme phosphotransacylase (PTAC) recycles Coenzyme A and generates an acyl phosphate that can serv
48 biosynthetic reaction which produces acetyl-coenzyme A and oxaloacetate from citrate and coenzyme A
55 imidine, isoprenoid, methionine, riboflavin, coenzyme A, and folate, as well as other biosynthetic pa
57 s the polymerization of 3-(R)-hydroxybutyryl-coenzyme A as a means of carbon storage in many bacteria
60 eracting partner, Golgi adaptor protein acyl-coenzyme A binding domain containing protein 3 (ACBD3).
61 uncover that the Golgi resident protein acyl-coenzyme A binding domain-containing 3 (ACBD3) serves as
62 ed experimental and simulation study of acyl-coenzyme A binding protein (ACBP), a two-state folder (f
63 emperature as the different variants of acyl-coenzyme A binding protein have similar m-values when th
64 re, we identify the PO membrane protein acyl-coenzyme A-binding domain protein 5 (ACBD5) as a binding
65 Low-molecular mass (10 kD) cytosolic acyl-coenzyme A-binding protein (ACBP) has a substantial infl
67 SAR-related proteins THIOREDOXIN h3, ACYL-COENZYME A-BINDING PROTEIN6, and PATHOGENESIS-RELATED1 w
70 cellulo and could be used to identify acetyl coenzyme A carboxylase (ACC) in Pseudomonas aeruginosa a
75 ption factor 1c, fatty acid synthase, acetyl coenzyme A carboxylase 2, and carnitine palmitoyltransfe
76 r with the biotin acceptor protein of acetyl-coenzyme A carboxylase and catalyzes posttranslational b
77 204-5p which was predicted to inhibit acetyl coenzyme A carboxylase beta, a key fatty acid oxidation
78 y the accumulation of plastid-encoded acetyl Coenzyme A carboxylase D proteins accounting for the gen
79 tural environments, where heteromeric acetyl-coenzyme A carboxylase encoded in part by the chloroplas
80 ctrophoretic (CE) assay for measuring acetyl coenzyme A carboxylase holoenzyme (holo-ACC) activity an
81 d nuclear gene that targets homomeric acetyl-coenzyme A carboxylase to plastids, where the multidomai
82 in ACC2, encoding a plastid-targeted acetyl-coenzyme A carboxylase, cause hypersensitivity to specti
83 ation of the AMPK substrates, p53 and acetyl-coenzyme A carboxylase, changes that correlated with inc
84 DI-010976, an allosteric inhibitor of acetyl-coenzyme A carboxylases (ACC) ACC1 and ACC2, reduces hep
86 3) Direct acetyl transfer between LD and coenzyme A catalyzed by E2pCD was observed with a rate c
88 physical interaction of the major SOAT, acyl-coenzyme A:cholesterol acyltransferase (ACAT)-related en
89 ress the cholesterol-esterifying enzyme acyl-coenzyme A:cholesterol acyltransferase (ACAT1), but not
90 ched-chain amino acid metabolism, isovaleryl-Coenzyme A (CoA) and isobutyryl-CoA, with three molecule
91 N-acyltransferase reaction using fatty acyl-coenzyme A (CoA) and long-chain base (LCB) substrates to
96 olution crystal structure of AF-Est2 reveals Coenzyme A (CoA) bound in the vicinity of the active sit
98 roduce mm flux through the key fluoromalonyl coenzyme A (CoA) building block, thereby offering the po
100 (OG) is a small molecule inhibitor of acetyl coenzyme A (CoA) carboxylase (ACC), the enzyme that cont
101 kinase (AMPK) levels, and diminished acetyl coenzyme A (CoA) carboxylase phosphorylation than in the
105 The Arabidopsis (Arabidopsis thaliana) acyl-coenzyme A (CoA) desaturase-like (ADS) gene family conta
106 p of the phenylpropanoid pathway, exchanging coenzyme A (CoA) esterified to p-coumaric acid with shik
107 catalyzes the reduction of hydroxycinnamoyl-coenzyme A (CoA) esters using NADPH to produce hydroxyci
109 metabolic machinery for the biosynthesis of Coenzyme A (CoA) from exogenous pantothenic acid (Vitami
110 eport the identification of a putative enoyl-coenzyme A (CoA) hydratase/isomerase that is required fo
112 ty of SPT, allowing utilization of myristoyl-coenzyme A (CoA) in addition to its canonical substrate
115 -HB-CoA to form 4-hydroxybenzoate (4-HB) and coenzyme A (CoA) in the final step of the 4-chlorobenzoa
119 ary and sequence information about conserved coenzyme A (CoA) ligase motifs, a cDNA encoding cinnamat
120 zyme DmdB, a methylmercaptopropionate (MMPA)-coenzyme A (CoA) ligase, catalyzes the second step in th
122 o enzymes, Ptr4CL3 and Ptr4CL5, catalyze the coenzyme A (CoA) ligation of 4-coumaric acid to 4-coumar
125 ation of the meta-hydroxyl group of caffeoyl-coenzyme A (CoA) on the pathway to monolignols, with the
127 enzymes catalyze the reduction of fatty acyl-coenzyme A (CoA) or fatty acyl-acyl carrier protein subs
128 ity were correlated with changes in the acyl-coenzyme A (CoA) pool in developing seeds of transgenic
129 cate that YacG is frequently associated with coenzyme A (CoA) production enzymes, linking the protein
130 transition pore (PTP) openings, followed by coenzyme A (CoA) release, acyl CoA synthesis, and membra
131 levels of intermediate and anaplerotic acyl-coenzyme A (CoA) species incorporated into the Krebs cyc
133 ferase activity when presented with caffeoyl-Coenzyme A (CoA) substrate, thus we have named this acyl
134 carbon-carbon bond forming step between acyl coenzyme A (CoA) substrates offer a versatile route for
137 essive missense mutations in COASY, encoding coenzyme A (CoA) synthase in one NBIA-affected subject.
138 tochondrion-associated long-chain fatty acyl coenzyme A (CoA) thioesterase that is highly expressed i
144 key role in metabolism as building blocks of coenzyme A (CoA), an essential cofactor utilized in ~4%
145 lysophosphatidylethanolamine (LPE) with acyl-coenzyme A (CoA), designated LYSOPHOSPHATIDYLETHANOLAMIN
147 ing the final and committed step in the acyl-coenzyme A (CoA)-dependent biosynthesis of triacylglycer
148 metabolites into 4-methyl-pentanol (4MP) via coenzyme A (CoA)-dependent chemistry were taken from nin
149 production of 1-butanol by the fermentative coenzyme A (CoA)-dependent pathway using the reversal of
160 we determined the structure for the FAD- and coenzyme A-containing holoenzyme from P. horikoshii to 2
161 ecreased the expression of medium-chain acyl coenzyme A dehydrogenase (MCAD) and short-chain acyl coe
162 A dehydrogenase (MCAD) and short-chain acyl coenzyme A dehydrogenase (SCAD), involved in the regulat
163 The hepatic activities of 3-hydroxyacyl-coenzyme A dehydrogenase short chain and glutamate dehyd
164 3 candidate gene, CTLA-4, NRAMP1, and acetyl-coenzyme A dehydrogenase, long-chain (ACADL) (candidate
165 mical analyses showed lower beta-hydroxyacyl coenzyme-A dehydrogenase activity and higher lactate deh
166 the response regulator CpxR and (ii) acetyl coenzyme A-dependent acetylation of the alpha subunit of
168 rrier protein) synthase (ACPS) catalyzes the coenzyme A-dependent activation of apo-ACPP to generate
169 unable to convert free fatty acids to their coenzyme A derivatives, accumulates free fatty acids dur
171 0 (P = 1.6 x 10(-8)) as a marker of stearoyl coenzyme A desaturase 1 activity, and the ratio of 20:3n
172 This review provides an overview of stearoyl-coenzyme A desaturase-1 (SCD1) as a novel therapeutic ta
173 ate (P-HPD, an isomer of AI-2-phosphate) and coenzyme A, determine the crystal structure of an LsrF c
174 ccumulation in sdp1 roots requires both ACYL-COENZYME A:DIACYLGLYCEROL ACYLTRANSFERASE1 (DGAT1) and P
175 of increased or decreased expression of ACYL-COENZYME A:DIACYLGLYCEROL ACYLTRANSFERASE1 (DGAT1) or PH
177 ex (PDHc), which converts pyruvate to acetyl coenzyme A, enables E. coli to resist these antimicrobia
179 es high carbon flux through the ethylmalonyl coenzyme A (ethylmalonyl-CoA) pathway (EMC pathway).
182 gen sources for protein synthesis and acetyl-coenzyme A for cytosol-localized fatty acid elongation.
183 e binding sites for both the upstream acetyl coenzyme A formation and fatty acid synthase modules ena
184 cast into three modules: the upstream acetyl coenzyme A formation module; the intermediary acetyl-CoA
185 The biosynthesis of the major acyl carrier Coenzyme A from pantothenic acid (PA) is critical for su
187 tein E (ApoE) and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGR)) has been linked t
188 inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase and subsequently the isop
189 Until recently, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) have
190 blockers (ARBs), 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins), and
191 e shown that the 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors known as stati
195 d by increased (14) C-glucose-derived acetyl-coenzyme A incorporation into sterols for fecal excretio
197 degradation through hydration of the dienoyl-coenzyme A intermediate as observed in Geobacter metalli
203 n Escherichia coli, synthesis of the malonyl coenzyme A (malonyl-CoA) required for membrane lipid syn
207 tion, we cloned and characterized a caffeoyl-coenzyme A O-methyltransferase (PhCCoAOMT1) from the pet
208 a-oxidation double mutant acx1acx2 (for acyl-Coenzyme A oxidase), levels of TAG actually increased in
209 s and in vivo rescue potential of the acetyl-Coenzyme A precursor S-acetyl-4'-phosphopantetheine as a
210 One therapeutic strategy is to generate Coenzyme A precursors downstream of the defective step i
213 (AT1) is shown to encode a hydroxycinnamoyl-coenzyme A:putrescine acyltransferase responsible for ca
214 spectrometric sequencing: a hydroxycinnamoyl-Coenzyme A:quinate hydroxycinnamoyl transferase (HQT) wa
217 olesterol, in the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) activity, and in the in vit
218 odies recognizing 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) are found in patients with
220 ombination with a 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) inhibitor (statin), will re
222 the formation of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), a main regulator of choles
223 ubiquitination of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), which catalyzes a rate-lim
225 ncoding PCSK9 and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR; the target of statins) as i
226 interfering with 3-hydroxy-3-methyl glutaryl coenzyme A reductase (HMGR) activity, a key player in is
227 tylase (HDAC) and 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) by having a hydroxamate grou
229 Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (statins) can modulate inflammatory
230 Inhibitors of 3-hydroxy-3-methylglutaryl-Coenzyme A reductase and isoprenylation attenuated, wher
231 ins targeting the 3-hydroxy-3-methylglutaryl coenzyme A reductase but also inhibitors of oxidosqualen
233 fects of statins, 3-hydroxy-3 methylglutaryl coenzyme A reductase inhibitor, have been shown to modif
235 es of the influence of hydroxymethylglutaryl-coenzyme A reductase inhibitors (also known as statins)
241 fects of statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) on renal, cardiovascula
243 er statins, 3-hydroxymethyl-3-methylglutaryl coenzyme A reductase inhibitors, are safe to use has bee
244 ted with elevated 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA levels and anti-Src-Tyr416 imm
245 osynthetic enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase results from its sterol-induced bin
246 roxylase) and ccr1g (deficient for cinnamoyl-coenzyme A reductase) lines, albeit to a lower extent.
247 protein 2, human 3-hydroxy-3-methylglutaryl-coenzyme A reductase, and human low-density lipoprotein
248 e-limiting enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase, and increased plasma membrane chol
249 rved lower activity of hydroxymethylglutaryl-coenzyme A reductase, the key enzyme in the mevalonate p
250 ically inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase, which is a rate-limiting enzyme fo
251 d proteolysis of 3-hydroxyl-3-methylglutaryl coenzyme A reductase, which may undermine other host res
252 e development of anti-hydroxymethyl glutaryl-coenzyme A reductase-positive statin-induced myopathy.
255 rget of pitavastatin, hydroxymethylglutarate coenzyme-A reductase (HMGCR), was found to be over-expre
256 tins, or HMG CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase inhibitors, are drugs with multipl
259 he genes encoding 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE1 (HMGR1) and MAKIBISHI1, the rate-l
260 ctly dependent on metabolites such as acetyl-coenzyme A, S-adenosylmethionine, and NAD+, among others
262 olignol biosynthetic enzyme hydroxycinnamoyl coenzyme A:shikimate hydroxycinnamoyl transferase (HCT)
267 onfirmed the role of a hydroxymethylglutaryl-coenzyme A synthase cassette, three flavin-dependent tai
268 Previously, it was shown that beta-ketoacyl-coenzyme A synthase ECERIFERUM6 (CER6) is necessary for
269 ein-based model for the NiP center of acetyl coenzyme A synthase using a nickel-substituted azurin pr
270 ox (hydrogenases and CO dehydrogenase/acetyl coenzyme A synthase), they have never been associated wi
271 nic genes such as 3-hydroxy-3-methylglutaryl-coenzyme A synthase, fatty acid synthase, and stearoyl-C
272 this study is to explore parasite fatty acyl-coenzyme A synthetase (ACS) as a novel drug target.
275 Although many Archaea have AMP-Acs (acetyl-coenzyme A synthetase) and ADP-Acs, the extant methanoge
276 ctroscopy, the cutin mutants long-chain acyl-coenzyme A synthetase2 (lacs2), permeable cuticle1 (pec1
277 enin polyketide biosynthetic metabolon (ACYL COENZYME A SYNTHETASE5, POLYKETIDE SYNTHASE A [PKSA], PK
278 is activation is mediated by long-chain acyl-coenzyme A synthetases (LACSs), which are encoded by a f
280 cycle for the generation of cytosolic acetyl-coenzyme A that can be used for fatty acid and cholester
281 need to be converted to their corresponding coenzyme A thioesters to become metabolically available.
283 talyze the sequential esterification of acyl-coenzyme A thioesters to the R4, R3, R3', and R2 positio
286 LDHA maintains high concentrations of acetyl-coenzyme A to enhance histone acetylation and transcript
287 m the FAR2-catalyzed reduction of fatty acyl-coenzyme A to fatty alcohols, which are possible precurs
288 n enzyme that catalyzes conversion of acetyl coenzyme A to malonyl coenzyme A, a carbon donor for lon
289 the transfer of an acetyl group from acetyl coenzyme A to polyamines such as spermidine and spermine
292 results suggest that OsAT10 is a p-coumaroyl coenzyme A transferase involved in glucuronoarabinoxylan
293 ss-expanded and -diverged clade of BAHD acyl-coenzyme A-utilizing transferases identified four mutant
294 the synthesis of nicotinate, NAD+, NADP+ and coenzyme A were detected among the essential vitamins an
296 for their mission: E1 and E2 generate acetyl-coenzyme A, whereas the FAD/NAD(+)-dependent E3 performs
297 onverted to the central intermediate benzoyl-coenzyme A, which is enzymatically reduced to cyclohexa-
298 ich decarboxylates pyruvate and forms acetyl-coenzyme A with concomitant reduction of low-potential f
300 he transfer of an acetyl group from P-HPD to coenzyme A yielding dihydroxyacetone phosphate and acety
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。